Ziegler, R.

Better late than never? Experience with intravenous pamidronate treatment in patients with low bone mass or fractures following cardiac or liver transplantation

Dodidou, P., Bruckner, T., Hosch, S., Haass, M., Klar, E., Sauer, P., Ziegler, R., & Leidig-Bruckner, G. (2003) · Osteoporosis International

Bone health and osteoporosis researchBone health and treatments

Cited by 57

Effects of 6 years of growth hormone (GH) treatment on bone mineral density in GH‐deficient adults

Clanget, C., Seck, T., Hinke, V., Wüster, C., Ziegler, R., & Pfeilschifter, J. (2001) · Clinical Endocrinology

Growth Hormone and Insulin-like Growth FactorsBone health and osteoporosis research

Cited by 42

Severe type III hyperlipoproteinemia associated with unusual apolipoprotein E1 phenotype and & epsilon;1/lsquo;null genotype‡

FEUSSNER, G., FUNKE, H., WENG, W., ASSMANN, G., LACKNER, K. J., & ZIEGLER, R. (1992) · European Journal of Clinical Investigation

Lipid metabolism and disordersLipoproteins and Cardiovascular Health

Cited by 28

Clinical features of type III hyperlipoproteinemia: analysis of 64 patients

Feussner, G., Wagner, A., Kohl, B., & Ziegler, R. (1993) · The Clinical Investigator

Lipid metabolism and disordersLipoproteins and Cardiovascular Health

Cited by 27

Response to therapy of a type III hyperlipoproteinemic subject with the rare apolipoprotein E1 (Gly127 ? Asp, Arg158 ? Cys) variant

Feussner, G., & Ziegler, R. (1992) · The Clinical Investigator

Lipid metabolism and disordersLipoproteins and Cardiovascular Health

Cited by 3